Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)

2020 ◽  
Author(s):  
Kristian Reich ◽  
Henrique D. Teixeira ◽  
Marjolein de Bruin-Weller ◽  
Thomas Bieber ◽  
Weily Soong ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Controlled Study ◽  
Severe Atopic Dermatitis ◽  
Phase 3 ◽  
Pivotal Phase ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Topical Corticosteroids ◽  
Adolescents And Adults

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

Vaccine ◽  
2013 ◽  
Vol 31 (28) ◽  
pp. 2963-2971 ◽  
Author(s):  
Robert A. Kuschner ◽  
Kevin L. Russell ◽  
Mary Abuja ◽  
Kristen M. Bauer ◽  
Dennis J. Faix ◽  
...  
Keyword(s):  
Adenovirus Type ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Military Recruits

Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study

2014 ◽  
Vol 133 (2) ◽  
pp. AB404 ◽  
Author(s):  
Thomas R.M. Bieber ◽  
Diamant Thaci ◽  
Neil Graham ◽  
Gianluca Pirozzi ◽  
Ariel Teper ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Controlled Study ◽  
Severe Atopic Dermatitis ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document